1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DNAJC9 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA HELLS CTRPv2 pan-cancer AAC 0.083 0.01
mRNA LRRIQ3 CTRPv2 pan-cancer AAC 0.082 0.01
mRNA SYNPO2 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA CD81 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA ZNF384 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA CNPPD1 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA PI4K2A CTRPv2 pan-cancer AAC -0.088 0.01
mRNA TMOD1 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA GPR22 CTRPv2 pan-cancer AAC -0.095 0.01
Download CSV